elosulfase alfa
VIMIZIM was approved for use in a specific patient who will receive infusions at HHWC.
Reviewed: April 22, 2014
VIMIZIM was approved for use in a specific patient who will receive infusions at HHWC.
Reviewed: April 22, 2014